aluates Reports

$ 0.0

Automative

Psoriasis Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-28R2574

Global Psoriasis Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Psoriasis Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-28R2574

Report

October 2024

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Amgen Inc

Johnson & Johnson

Novartis

Eli lilly company

Astrazeneca plc

Celgene Corporation

UCB

Merck

Psoriasis Drugs - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Psoriasis Drugs - Market

The global market for Psoriasis Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Psoriasis Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Psoriasis Drugs by region & country, by Type, and by Application.

The Psoriasis Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriasis Drugs.

Market Segmentation

Scope of Psoriasis Drugs - Market Report

Report Metric	Details
Report Name	Psoriasis Drugs - Market
CAGR	5%
Segment by Type:	Tumor Necrosis Factor Inhibitor Interleukin Inhibitors Others
Segment by Application	Topicals Systemic Biologics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Amgen, Johnson & Johnson, Novartis, Eli Lilly & Company, AstraZeneca, Celgene Corporation, UCB, Merck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Psoriasis Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Psoriasis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Psoriasis Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Psoriasis Drugs - Market report?

Ans: The main players in the Psoriasis Drugs - Market are AbbVie, Amgen, Johnson & Johnson, Novartis, Eli Lilly & Company, AstraZeneca, Celgene Corporation, UCB, Merck

What are the Application segmentation covered in the Psoriasis Drugs - Market report?

Ans: The Applications covered in the Psoriasis Drugs - Market report are Topicals, Systemic, Biologics

What are the Type segmentation covered in the Psoriasis Drugs - Market report?

Ans: The Types covered in the Psoriasis Drugs - Market report are Tumor Necrosis Factor Inhibitor, Interleukin Inhibitors, Others

1 Market Overview

1.1 Psoriasis Drugs Product Introduction

1.2 Global Psoriasis Drugs Market Size Forecast

1.3 Psoriasis Drugs Market Trends & Drivers

1.3.1 Psoriasis Drugs Industry Trends

1.3.2 Psoriasis Drugs Market Drivers & Opportunity

1.3.3 Psoriasis Drugs Market Challenges

1.3.4 Psoriasis Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Psoriasis Drugs Players Revenue Ranking (2023)

2.2 Global Psoriasis Drugs Revenue by Company (2019-2024)

2.3 Key Companies Psoriasis Drugs Manufacturing Base Distribution and Headquarters

2.4 Key Companies Psoriasis Drugs Product Offered

2.5 Key Companies Time to Begin Mass Production of Psoriasis Drugs

2.6 Psoriasis Drugs Market Competitive Analysis

2.6.1 Psoriasis Drugs Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Psoriasis Drugs Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Drugs as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Tumor Necrosis Factor Inhibitor

3.1.2 Interleukin Inhibitors

3.1.3 Others

3.2 Global Psoriasis Drugs Sales Value by Type

3.2.1 Global Psoriasis Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Psoriasis Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Psoriasis Drugs Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Topicals

4.1.2 Systemic

4.1.3 Biologics

4.2 Global Psoriasis Drugs Sales Value by Application

4.2.1 Global Psoriasis Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Psoriasis Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Psoriasis Drugs Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Psoriasis Drugs Sales Value by Region

5.1.1 Global Psoriasis Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Psoriasis Drugs Sales Value by Region (2019-2024)

5.1.3 Global Psoriasis Drugs Sales Value by Region (2025-2030)

5.1.4 Global Psoriasis Drugs Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Psoriasis Drugs Sales Value, 2019-2030

5.2.2 North America Psoriasis Drugs Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Psoriasis Drugs Sales Value, 2019-2030

5.3.2 Europe Psoriasis Drugs Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Psoriasis Drugs Sales Value, 2019-2030

5.4.2 Asia Pacific Psoriasis Drugs Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Psoriasis Drugs Sales Value, 2019-2030

5.5.2 South America Psoriasis Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Psoriasis Drugs Sales Value, 2019-2030

5.6.2 Middle East & Africa Psoriasis Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Psoriasis Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Psoriasis Drugs Sales Value

6.3 United States

6.3.1 United States Psoriasis Drugs Sales Value, 2019-2030

6.3.2 United States Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Psoriasis Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Psoriasis Drugs Sales Value, 2019-2030

6.4.2 Europe Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Psoriasis Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Psoriasis Drugs Sales Value, 2019-2030

6.5.2 China Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Psoriasis Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Psoriasis Drugs Sales Value, 2019-2030

6.6.2 Japan Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Psoriasis Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Psoriasis Drugs Sales Value, 2019-2030

6.7.2 South Korea Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Psoriasis Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Psoriasis Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Psoriasis Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Psoriasis Drugs Sales Value, 2019-2030

6.9.2 India Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Psoriasis Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AbbVie

7.1.1 AbbVie Profile

7.1.2 AbbVie Main Business

7.1.3 AbbVie Psoriasis Drugs Products, Services and Solutions

7.1.4 AbbVie Psoriasis Drugs Revenue (US$ Million) & (2019-2024)

7.1.5 AbbVie Recent Developments

7.2 Amgen

7.2.1 Amgen Profile

7.2.2 Amgen Main Business

7.2.3 Amgen Psoriasis Drugs Products, Services and Solutions

7.2.4 Amgen Psoriasis Drugs Revenue (US$ Million) & (2019-2024)

7.2.5 Amgen Recent Developments

7.3 Johnson & Johnson

7.3.1 Johnson & Johnson Profile

7.3.2 Johnson & Johnson Main Business

7.3.3 Johnson & Johnson Psoriasis Drugs Products, Services and Solutions

7.3.4 Johnson & Johnson Psoriasis Drugs Revenue (US$ Million) & (2019-2024)

7.3.5 Novartis Recent Developments

7.4 Novartis

7.4.1 Novartis Profile

7.4.2 Novartis Main Business

7.4.3 Novartis Psoriasis Drugs Products, Services and Solutions

7.4.4 Novartis Psoriasis Drugs Revenue (US$ Million) & (2019-2024)

7.4.5 Novartis Recent Developments

7.5 Eli Lilly & Company

7.5.1 Eli Lilly & Company Profile

7.5.2 Eli Lilly & Company Main Business

7.5.3 Eli Lilly & Company Psoriasis Drugs Products, Services and Solutions

7.5.4 Eli Lilly & Company Psoriasis Drugs Revenue (US$ Million) & (2019-2024)

7.5.5 Eli Lilly & Company Recent Developments

7.6 AstraZeneca

7.6.1 AstraZeneca Profile

7.6.2 AstraZeneca Main Business

7.6.3 AstraZeneca Psoriasis Drugs Products, Services and Solutions

7.6.4 AstraZeneca Psoriasis Drugs Revenue (US$ Million) & (2019-2024)

7.6.5 AstraZeneca Recent Developments

7.7 Celgene Corporation

7.7.1 Celgene Corporation Profile

7.7.2 Celgene Corporation Main Business

7.7.3 Celgene Corporation Psoriasis Drugs Products, Services and Solutions

7.7.4 Celgene Corporation Psoriasis Drugs Revenue (US$ Million) & (2019-2024)

7.7.5 Celgene Corporation Recent Developments

7.8 UCB

7.8.1 UCB Profile

7.8.2 UCB Main Business

7.8.3 UCB Psoriasis Drugs Products, Services and Solutions

7.8.4 UCB Psoriasis Drugs Revenue (US$ Million) & (2019-2024)

7.8.5 UCB Recent Developments

7.9 Merck

7.9.1 Merck Profile

7.9.2 Merck Main Business

7.9.3 Merck Psoriasis Drugs Products, Services and Solutions

7.9.4 Merck Psoriasis Drugs Revenue (US$ Million) & (2019-2024)

7.9.5 Merck Recent Developments

8 Industry Chain Analysis

8.1 Psoriasis Drugs Industrial Chain

8.2 Psoriasis Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Psoriasis Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Psoriasis Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

AbbVie

Amgen Inc

Johnson & Johnson

Novartis

Eli lilly company

Astrazeneca plc

Celgene Corporation

UCB

Merck

List of Tables

Table 1. Psoriasis Drugs Market Trends

Table 2. Psoriasis Drugs Market Drivers & Opportunity

Table 3. Psoriasis Drugs Market Challenges

Table 4. Psoriasis Drugs Market Restraints

Table 5. Global Psoriasis Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Psoriasis Drugs Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Psoriasis Drugs Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Psoriasis Drugs Product Type

Table 9. Key Companies Time to Begin Mass Production of Psoriasis Drugs

Table 10. Global Psoriasis Drugs Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Drugs as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Psoriasis Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Psoriasis Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Psoriasis Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Psoriasis Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Psoriasis Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Psoriasis Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Psoriasis Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Psoriasis Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Psoriasis Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Psoriasis Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Psoriasis Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Psoriasis Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Psoriasis Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Psoriasis Drugs Sales Value by Region (2019-2024) & (%)

Table 27. Global Psoriasis Drugs Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Psoriasis Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Psoriasis Drugs Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Psoriasis Drugs Sales Value, (2025-2030) & (US$ Million)

Table 31. AbbVie Basic Information List

Table 32. AbbVie Description and Business Overview

Table 33. AbbVie Psoriasis Drugs Products, Services and Solutions

Table 34. Revenue (US$ Million) in Psoriasis Drugs Business of AbbVie (2019-2024)

Table 35. AbbVie Recent Developments

Table 36. Amgen Basic Information List

Table 37. Amgen Description and Business Overview

Table 38. Amgen Psoriasis Drugs Products, Services and Solutions

Table 39. Revenue (US$ Million) in Psoriasis Drugs Business of Amgen (2019-2024)

Table 40. Amgen Recent Developments

Table 41. Johnson & Johnson Basic Information List

Table 42. Johnson & Johnson Description and Business Overview

Table 43. Johnson & Johnson Psoriasis Drugs Products, Services and Solutions

Table 44. Revenue (US$ Million) in Psoriasis Drugs Business of Johnson & Johnson (2019-2024)

Table 45. Johnson & Johnson Recent Developments

Table 46. Novartis Basic Information List

Table 47. Novartis Description and Business Overview

Table 48. Novartis Psoriasis Drugs Products, Services and Solutions

Table 49. Revenue (US$ Million) in Psoriasis Drugs Business of Novartis (2019-2024)

Table 50. Novartis Recent Developments

Table 51. Eli Lilly & Company Basic Information List

Table 52. Eli Lilly & Company Description and Business Overview

Table 53. Eli Lilly & Company Psoriasis Drugs Products, Services and Solutions

Table 54. Revenue (US$ Million) in Psoriasis Drugs Business of Eli Lilly & Company (2019-2024)

Table 55. Eli Lilly & Company Recent Developments

Table 56. AstraZeneca Basic Information List

Table 57. AstraZeneca Description and Business Overview

Table 58. AstraZeneca Psoriasis Drugs Products, Services and Solutions

Table 59. Revenue (US$ Million) in Psoriasis Drugs Business of AstraZeneca (2019-2024)

Table 60. AstraZeneca Recent Developments

Table 61. Celgene Corporation Basic Information List

Table 62. Celgene Corporation Description and Business Overview

Table 63. Celgene Corporation Psoriasis Drugs Products, Services and Solutions

Table 64. Revenue (US$ Million) in Psoriasis Drugs Business of Celgene Corporation (2019-2024)

Table 65. Celgene Corporation Recent Developments

Table 66. UCB Basic Information List

Table 67. UCB Description and Business Overview

Table 68. UCB Psoriasis Drugs Products, Services and Solutions

Table 69. Revenue (US$ Million) in Psoriasis Drugs Business of UCB (2019-2024)

Table 70. UCB Recent Developments

Table 71. Merck Basic Information List

Table 72. Merck Description and Business Overview

Table 73. Merck Psoriasis Drugs Products, Services and Solutions

Table 74. Revenue (US$ Million) in Psoriasis Drugs Business of Merck (2019-2024)

Table 75. Merck Recent Developments

Table 76. Key Raw Materials Lists

Table 77. Raw Materials Key Suppliers Lists

Table 78. Psoriasis Drugs Downstream Customers

Table 79. Psoriasis Drugs Distributors List

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

Table 83. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Psoriasis Drugs Product Picture

Figure 2. Global Psoriasis Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Psoriasis Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Psoriasis Drugs Report Years Considered

Figure 5. Global Psoriasis Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Psoriasis Drugs Revenue in 2023

Figure 7. Psoriasis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Tumor Necrosis Factor Inhibitor Picture

Figure 9. Interleukin Inhibitors Picture

Figure 10. Others Picture

Figure 11. Global Psoriasis Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Psoriasis Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Topicals

Figure 14. Product Picture of Systemic

Figure 15. Product Picture of Biologics

Figure 16. Global Psoriasis Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Psoriasis Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Psoriasis Drugs Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Psoriasis Drugs Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Psoriasis Drugs Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Psoriasis Drugs Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Psoriasis Drugs Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Psoriasis Drugs Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Psoriasis Drugs Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Psoriasis Drugs Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Psoriasis Drugs Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Psoriasis Drugs Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Psoriasis Drugs Sales Value (%), (2019-2030)

Figure 29. United States Psoriasis Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Psoriasis Drugs Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Psoriasis Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Psoriasis Drugs Sales Value by Application (%), 2023 VS 2030

Figure 35. China Psoriasis Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

Figure 37. China Psoriasis Drugs Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Psoriasis Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Psoriasis Drugs Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Psoriasis Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Psoriasis Drugs Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Psoriasis Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Psoriasis Drugs Sales Value by Application (%), 2023 VS 2030

Figure 47. India Psoriasis Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Psoriasis Drugs Sales Value by Type (%), 2023 VS 2030

Figure 49. India Psoriasis Drugs Sales Value by Application (%), 2023 VS 2030

Figure 50. Psoriasis Drugs Industrial Chain

Figure 51. Psoriasis Drugs Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions